CHKB-AS1 enhances proliferation and resistance to NVP-BEZ235 of renal cancer cells via regulating the phosphorylation of MAP4 and PI3K/AKT/mTOR signaling.

Eur J Med Res · 2023 · PMC10720114 · PMID 38093375

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

Besides, the protein level of cyclin D1 also displayed a positive trend with MAP4 alteration, indicating the significant activation of upstream pathway PI3k/Akt/mTOR.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.